Ennio Schwind

Ennio is a member of the Patents Technology & Life Sciences Practice Area. His practice focuses on advising and representing national and international pharmaceutical companies and medical device manufacturers, with a particular emphasis on regulatory issues in the field of pharmaceutical and medical device law.

专长

执业领域和服务团队

纠纷和调查

专利与创新

产品责任与产品安全

行业

酒店与休闲

生物技术

数字医疗

医疗器械

制药

CV

Since 2023 Associate, Taylor Wessing

2019 - 2021 Graduate research assistant, Fieldfisher

2023 Admission to the bar, Munich

2022 Second state law examination, Munich

2020 - 2022 Legal clerkship at the Higher Regional Court of Munich with a traineeship at Taylor Wessing

2019 - 2020 Master of Law (LL.M. Eur.) in European and International Business Law, Ludwig-Maximilians-University, Munich

2020 Semester abroad, University of Padua

2019 First State Examination in Law, Munich

2013 - 2019 Law studies, Ludwig-Maximilians-University, Munich

职业发展

Since 2023 Associate, Taylor Wessing

2019 - 2021 Graduate research assistant, Fieldfisher

教育

2023 Admission to the bar, Munich

2022 Second state law examination, Munich

2020 - 2022 Legal clerkship at the Higher Regional Court of Munich with a traineeship at Taylor Wessing

2019 - 2020 Master of Law (LL.M. Eur.) in European and International Business Law, Ludwig-Maximilians-University, Munich

2020 Semester abroad, University of Padua

2019 First State Examination in Law, Munich

2013 - 2019 Law studies, Ludwig-Maximilians-University, Munich

Publications

Offene Fragen nach den neuesten EuGH-Urteilen zum Umpacken von Arzneimitteln, in: A&R 2023, zusammen mit Dr. Daniel Tietjen

Artificial Intelligence Act (AIA) – neue Herausforderungen für Hersteller von KI-Medizinprodukten, in: ZdiW, Heft 12 2021, S. 458 ff., gemeinsam mit Dr. Daniel Tietjen

Die behördliche Sonderzulassung von Medizinprodukten – zunehmende praktische Relevanz durch die Einführung der MDR, in: MPR, Heft 2 2020, S. 46 ff., gemeinsam mit Dr. Cord Willhöft